CXCR4 and pancreatic neoplasm: Our data show that the induced chemoresistance is partly mediated by the activation of Akt and ERK signalling pathways and a small-molecule antagonist against CXCR4 can effectively abrogate the survival signals and resensitise the pancreatic cancer cells to gemcitabine cytotoxicity.